AI in Medical Writing Market Size, Share, By Type (Scientific Publications, Type Writing, Clinical Writing, Patient Documentation, Regulatory Writing, Health Communication, and Others) By Writing Tools (ChatGPT, Contentbot.ai, Knowledge Graphs, Jasper, Abridge, and Others), By End User (Healthcare Organizations, Pharmaceutical Industry, Medical Research Institutions, Medical Publishers, Contract Research Organizations, and Others) and By Region - Trends, Analysis and Forecast till 2034
Consumers increasing preference for algae-based products is one of the major trends driving growth of target market. Additionally, rising vegetarianism, increasing demand for natural food colors are some of the factor propelling the growth of the global market. Furthermore, the growing demand for biofuels is expected to boost the growth of the market during forecast period.
AI in Medical Writing Market Report Highlights:
- In 2023, AI in medical writing market was estimated to be worth USD 760.8 Billion.
- The target market is anticipated to reach USD 2367.1 billion by 2034.
- Target market is expanding at a CAGR of 13.3%.
- North America held the largest share of the market in 2024.
- Asia Pacific is projected to be the fastest-growing market in the coming years.
- By type, type writing dominate the target market growth.
- By writing tools, ChatGPT holds the largest share of the market.
- By end-user, healthcare organizations dominate the target market growth.
AI in Medical Writing Market Key Highlights:
- In July 2024, Cognizant and Yseop, a leading AI software company, have announced a plan to partner to help accurate and scale the delivery of scientific content in the biopharma industry through generative AI. The companies are hoping to enhancing productivity in the development process and expedite the market introduction of new, life-saving treatments.
- In June 2024, Certara Inc., a global leader in model-informed drug development, unveiled its next generation CoAuthor regulatory writing software which is an advanced writing platform designed for medical writers.
- In March 2024, Clinicians at Stanford Health Care will soon have access to an AI-powered app that can securely listen to interactions with patients and automatically generate draft clinical notes. The app, which was recently tested in a pilot program at Stanford Health Care, harnesses ambient voice recognition technology for creating a written summary which captures essential clinical details.
AI in Medical Writing Market Report Analysis:
For instance, according to the research report published by Elsevier B.V., in September 2024, Artificial intelligence (AI) has transformed medical writing, posing ethical and quality challenges. Med-PaLM 2 scored 86.5% on the USMLE, however there was little scientific consensus about adherence. The debate around the use of artificial intelligence (AI) into scientific writing has already sparked widespread attention in the medical and biological sciences. While artificial intelligence (AI) can surely speed up the process of document generation and revision, it also raises many concerns. The intersection of AI and health sciences is relatively new, but the usage of AI technologies by physicians and other scientists working in the life sciences is rapidly expanding.
Browse ∼50 market data tables and ∼45 figures through ∼189 slides and in-depth TOC on “AI in Medical Writing Market Size, Share, By Type (Scientific Publications, Type Writing, Clinical Writing, Patient Documentation, Regulatory Writing, Health Communication, and Others), Writing Tools (ChatGPT, Contentbot.ai, Knowledge Graphs, Jasper, Abridge, and Others), End-User (Healthcare Organizations, Pharmaceutical Industry, Medical Research Institutions, Medical Publishers, Contract Research Organizations, and Others) and Region - Trends, Analysis, and Forecast till 2034”
AI in Medical Writing Market Competitive Landscape:
The key players operating in the AI in medical writing market are Cactus Communication, CureMetrix Inc., Elsevier, Freyr, GENINVO, Parexel International Corporation, Trilogy Writing & Consulting GmbH, IQVIA, The Philips Group Oncology Communications, Inc., Medidata Solutions, John Wiley & Sons, Inc., Springer Nature, Intuitive Surgical, Dezzai, and MMS Holdings Inc.